Search Results Search Sort by RelevanceMost Recent Case and Commentary Sep 2004 Reproductive Rights, Commentary 1 Watson A. Bowes Jr., MD Virtual Mentor. 2004;6(9):387-389. doi: 10.1001/virtualmentor.2004.6.9.ccas2-0409. Case and Commentary Sep 2004 Reproductive Rights, Commentary 2 Karen E. Adams, MD and Martin T. Donohoe, MD Virtual Mentor. 2004;6(9):389-391. doi: 10.1001/virtualmentor.2004.6.9.ccas2-0409. Viewpoint Apr 2014 Inappropriate Obstructions to Access: The FDA’s Handling of Plan B Susan F. Wood, PhD The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions. Virtual Mentor. 2014;16(4):295-301. doi: 10.1001/virtualmentor.2014.16.4.oped1-1404.
Case and Commentary Sep 2004 Reproductive Rights, Commentary 1 Watson A. Bowes Jr., MD Virtual Mentor. 2004;6(9):387-389. doi: 10.1001/virtualmentor.2004.6.9.ccas2-0409.
Case and Commentary Sep 2004 Reproductive Rights, Commentary 2 Karen E. Adams, MD and Martin T. Donohoe, MD Virtual Mentor. 2004;6(9):389-391. doi: 10.1001/virtualmentor.2004.6.9.ccas2-0409.
Viewpoint Apr 2014 Inappropriate Obstructions to Access: The FDA’s Handling of Plan B Susan F. Wood, PhD The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions. Virtual Mentor. 2014;16(4):295-301. doi: 10.1001/virtualmentor.2014.16.4.oped1-1404.